Clinical trials recruiting in Friedrichshafen, Germany
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 2Phase 4 2Not applicable 3
Conditions recruiting in Friedrichshafen, Germany
Recruiting trials in Friedrichshafen, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
- Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer
- Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
- Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
- Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Common questions
How many clinical trials are recruiting in Friedrichshafen, Germany?
8 recruiting trials have at least one study site in Friedrichshafen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.